Inhibition of the Formation In Vitro of Putatively Carcinogenic Metabolites Derived from
Acetylcysteine
/ chemistry
Animals
Antioxidants
/ pharmacology
Carcinogenesis
/ drug effects
Carcinogens
/ chemistry
DNA Adducts
/ drug effects
Drug Combinations
Humans
Metabolome
/ drug effects
Neoplasms
/ drug therapy
Opisthorchiasis
/ complications
Opisthorchis
/ drug effects
Praziquantel
/ pharmacology
Resveratrol
/ pharmacology
Schistosoma haematobium
/ drug effects
Schistosomiasis haematobia
/ complications
CYP enzymes
DNA adducts
antioxidants
carcinogenesis
drug combination
drug repurposing
helminth infections
Journal
Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009
Informations de publication
Date de publication:
25 Oct 2019
25 Oct 2019
Historique:
received:
24
09
2019
revised:
22
10
2019
accepted:
22
10
2019
entrez:
17
11
2019
pubmed:
17
11
2019
medline:
24
4
2020
Statut:
epublish
Résumé
Infections caused by
Identifiants
pubmed: 31731402
pii: molecules24213842
doi: 10.3390/molecules24213842
pmc: PMC6864706
pii:
doi:
Substances chimiques
Antioxidants
0
Carcinogens
0
DNA Adducts
0
Drug Combinations
0
Praziquantel
6490C9U457
Resveratrol
Q369O8926L
Acetylcysteine
WYQ7N0BPYC
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Fundação para a Ciência e a Tecnologia
ID : IF/00092/2014/CP1255/CT0004
Organisme : Programa Operacional Temático Factores de Competitividade
ID : POCI-01-0145-FEDER-007274
Références
PLoS Negl Trop Dis. 2015 Dec 01;9(12):e0004258
pubmed: 26625139
PLoS Med. 2007 Jul;4(7):e201
pubmed: 17622191
Acta Trop. 2011 Sep;120 Suppl 1:S158-68
pubmed: 20655862
Clin Microbiol Rev. 1999 Jan;12(1):97-111
pubmed: 9880476
Biomolecules. 2019 Feb 05;9(2):
pubmed: 30764562
Drug Resist Updat. 1998;1(4):236-41
pubmed: 16904406
Int J Parasitol Drugs Drug Resist. 2014 Jul 30;4(3):185-200
pubmed: 25516827
Malar J. 2011 Sep 13;10:263
pubmed: 21914160
Clin Transl Med. 2016 Mar;5(1):12
pubmed: 26979321
Int J Cancer. 2006 Jun 15;118(12):3030-44
pubmed: 16404738
Free Radic Biol Med. 2011 Jan 1;50(1):78-85
pubmed: 20934508
Crit Rev Food Sci Nutr. 2009 Oct;49(9):782-99
pubmed: 20443159
Curr Opin Infect Dis. 2005 Dec;18(6):531-6
pubmed: 16258328
Int J Parasitol. 2013 Jan;43(1):17-26
pubmed: 23260770
Carcinogenesis. 2017 Sep 1;38(9):929-937
pubmed: 28910999
Parasitol Res. 2012 Nov;111(5):1871-7
pubmed: 23052781
Mol Nutr Food Res. 2009 Oct;53(10):1316-28
pubmed: 19753608
Pharmacol Ther. 2013 Apr;138(1):103-41
pubmed: 23333322
J Control Release. 2006 Jul 20;113(3):189-207
pubmed: 16790290
Molecules. 2018 Sep 11;23(9):
pubmed: 30208629
Trends Parasitol. 2012 Oct;28(10):395-407
pubmed: 22947297
Parasitol Res. 2003 Jun;90 Supp 1:S3-9
pubmed: 12811543
Exp Parasitol. 2017 Mar;174:52-58
pubmed: 28167208
Lancet. 2014 Jun 28;383(9936):2253-64
pubmed: 24698483
FEBS Lett. 2002 May 22;519(1-3):205-9
pubmed: 12023046
Front Genet. 2014 Dec 23;5:444
pubmed: 25566326
Free Radic Biol Med. 2010 Aug 1;49(3):392-400
pubmed: 20472053
Exp Parasitol. 2010 Dec;126(4):526-35
pubmed: 20547157
Trends Cancer. 2015 Nov 1;1(3):174-182
pubmed: 26618199
Parasitol Int. 2013 Dec;62(6):535-42
pubmed: 23973383
Infect Agent Cancer. 2019 Nov 29;14:41
pubmed: 31798678
PLoS Pathog. 2017 Jul 27;13(7):e1006393
pubmed: 28750101
BMC Cancer. 2014 May 10;14:331
pubmed: 24885752
Antimicrob Agents Chemother. 2017 Apr 24;61(5):
pubmed: 28264841
Mol Biochem Parasitol. 2012 Feb;181(2):190-4
pubmed: 22115821
Metabolism. 2007 Jul;56(7):887-94
pubmed: 17570247
IARC Monogr Eval Carcinog Risks Hum. 2012;100(Pt B):1-441
pubmed: 23189750
Trans R Soc Trop Med Hyg. 2006 Sep;100(9):847-54
pubmed: 16443246
J Clin Invest. 2008 Apr;118(4):1311-21
pubmed: 18382743
Parasit Vectors. 2019 Jun 20;12(1):309
pubmed: 31221193
Acta Pol Pharm. 2006 Sep-Oct;63(5):381-5
pubmed: 17357589
Cancer Lett. 2015 Apr 10;359(2):226-32
pubmed: 25615421